Vabysmo

Worked on the January 2022 launch of Vabysmo (Genentech) as lead art director on the below pieces:

Patient Brochures: 3 patient brochures were developed specific to each of Vabysmo’s indications. Each utilized a slight variation of the branding to differentiate the indications while maintaining consistency between the 3 as a collection of Vabysmo patient pieces. These were a core piece within the Vabysmo launch materials.

Now Approved Pre-OPDP Patient Website: To soft-launch the branding ahead of the Vabysmo launch, we used the eye shape at the center of the logo as a framing element for patient imagery.